Results of Tenax Therapeutics' Phase 2 HELP study of levosimendan in patients with pulmonary hypertension (PH) with heart failure with preserved ejection fraction (HFpEF) demonstrated that IV ...

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in a fireside chat at the 2024 ...

FDA approved the Varipulse pulsed field ablation (PFA) platform for drug refractory paroxysmal atrial fibrillation, Johnson & ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11%, a study shows.

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) – Analysts at HC Wainwright lifted their FY2024 earnings estimates for ...

The Finnish epilepsy care pathway has been published in Epilepsia Open. This Finnish model for epilepsy care provides a streamlined, multidisciplinary approach to the diagnosis and treatment of ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

The field of cardiovascular research has traditionally focused on the left heart's function, particularly in the context of left heart diseases (LHD), leading to significant advancements in ...